Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on HBV Cure 2019

Viral Hepatitis and Liver Disease

Stopping Nucleos(t)ide Analogues - Pietro Lampertico, MD, PhD

Viral Hepatitis and Liver Disease

Virological Biomarkers in Patients Stopping NUCs - Florian van Bommel, MD

Viral Hepatitis and Liver Disease

Review of the FDA/EMA HBV Endpoints Meeting - Fabien Zoulim, MD, PhD

Viral Hepatitis and Liver Disease

Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers? - Florian van Bommel, MD

Viral Hepatitis and Liver Disease

Are ALT Flares Associated with Improved Virological Clearance? - Harry L.A. Janssen, MD, PhD

Viral Hepatitis and Liver Disease

High Resolution of Exhausted T Cells Ex Vivo in Chronic HBV Infection - Robert Thimme, MD

Viral Hepatitis and Liver Disease

Restoration of B Cell Antibody Production in Chronic HBV Patients - Mala Maini, MD, PhD

Viral Hepatitis and Liver Disease

Using FNAB to Investigate Intrahepatic Immunology - Adam Gehring, PhD

Viral Hepatitis and Liver Disease

Gilead TLR8 Agonist (GS-9688) - Simon Fletcher, PhD

Viral Hepatitis and Liver Disease

Roche TLR-7 Agonist - Lu Gao, PhD

Viral Hepatitis and Liver Disease

Capsid Inhibitor/cccDNA Inhibitor--Roche - Lu Gao, PhD

Viral Hepatitis and Liver Disease

sIRNA-Based Therapy for Chronic Hepatitis B Treatment - Michael Biermer, PhD

Viral Hepatitis and Liver Disease

NAP's Latest Update in HBV and HDV - Andrew Vaillant, PhD

Viral Hepatitis and Liver Disease

HDV Trials - Robert G. Gish, MD

Viral Hepatitis and Liver Disease

Hypothesized Synergies in New Combination Treatment Beyond NUCs - Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

Study Design with New Combinations - Marion Peters, MD